Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06618586 · ClinicalTrials.gov registry record · NA

Get Social Media and Risk-Reduction Training

A NA study of Infant Death and Sudden Infant Death, sponsored by University of Virginia.

Recruiting
Registry status
NA
Development phase
10,000
Enrollment target
1
Study location

NCT06618586 is a NA study of Infant Death and Sudden Infant Death that is actively recruiting participants, run by University of Virginia. The registered enrollment target is 10,000 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06618586, a NA study of Infant Death and Sudden Infant Death, is actively recruiting participants, sponsored by University of Virginia.

RECRUITING
Registry status
NA
Development phase
10,000 participants
Enrollment target
1
Study location

Study Summary

This study examines the implementation of the TodaysBaby™ mobile safe sleep intervention program in US hospitals. The main aims of this study are to examine: 1) differences in program penetration and the equity of penetration according to income and race/ethnicity; 2) differences in feasibility, acceptability, sustainability and fidelity top the intervention; and 3) the effectiveness of the intervention.

Interventions

  • BEHAVIORAL TodaysBaby

Study Locations (1)

Massachusetts

  • Boston University - Boston

Trial Details

FieldValue
Enrollment Target 10,000 participants
Start Date 2025-05-01
Est. Completion 2028-06-01
Phase NA

Sponsor

University of Virginia

449 total trials

What the Registry Record Tells You About NCT06618586

The ClinicalTrials.gov registry entry for NCT06618586 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 10,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Infant Death appearing as the primary indexed condition, and to 1 intervention - of which TodaysBaby is the first listed.

NCT06618586 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06618586 about?

NCT06618586 is a clinical study titled "Get Social Media and Risk-Reduction Training". This study examines the implementation of the TodaysBaby™ mobile safe sleep intervention program in US hospitals. The main aims of this study are to examine: 1) differences in program penetration and the equity of penetration according to income and race/ethnicity; 2) differences in feasibility, acc...

What is the current status of trial NCT06618586?

This trial is currently recruiting. It is a NA study. The enrollment target is 10,000 participants. The study started on 2025-05-01. Estimated completion is 2028-06-01.

What conditions does trial NCT06618586 study?

This clinical trial studies the following conditions: Infant Death, Sudden Infant Death.

What interventions are being tested in trial NCT06618586?

The interventions under investigation include: TodaysBaby (BEHAVIORAL).

Who is sponsoring clinical trial NCT06618586?

This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06618586 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Infant Death

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.